Invention Grant
- Patent Title: Anaplastic lymphoma kinase modulators and methods of use
- Patent Title (中): 间变性淋巴瘤激酶调节剂及其使用方法
-
Application No.: US10565657Application Date: 2004-07-23
-
Publication No.: US07872014B2Publication Date: 2011-01-18
- Inventor: Neel Kumar Anand , Charles M. Blazey , Owen Joseph Bowles , Joerg Bussenius , Simona Costanzo , Jeffry Kimo Curtis , Larisa Dubenko , Abigail R. Kennedy , Richard G. Khoury , Angie I. Kim , Jean-Claire L. Manalo , Csaba J. Peto , Kenneth D. Rice , Tsze H. Tsang
- Applicant: Neel Kumar Anand , Charles M. Blazey , Owen Joseph Bowles , Joerg Bussenius , Simona Costanzo , Jeffry Kimo Curtis , Larisa Dubenko , Abigail R. Kennedy , Richard G. Khoury , Angie I. Kim , Jean-Claire L. Manalo , Csaba J. Peto , Kenneth D. Rice , Tsze H. Tsang
- Applicant Address: US CA South San Francisco
- Assignee: Exelixis, Inc.
- Current Assignee: Exelixis, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- International Application: PCT/US2004/023762 WO 20040723
- International Announcement: WO2005/009389 WO 20050203
- Main IPC: C07D471/02
- IPC: C07D471/02 ; A61K31/4745
Abstract:
The present invention comprises compounds and pharmaceutical compositions comprising the compounds that are inhibitors of ALK. The invention also comprises methods of using the compounds and compositions to treat diseases mediated by ALK, including diseases such as cancer, immunological disorders, cardiovascular diseases, and other degenerative disorders.
Public/Granted literature
- US20070032515A1 Anaplastic lymphoma kinase modulators and methods of use Public/Granted day:2007-02-08
Information query
